Newsletter Archive

1. 09.10.25 -- Translating an Early-Stage mRNA Therapeutic Into The Clinic 9/10/2025
   09/10/25 Advancing RNA Newsletter
2. 09.03.25 -- CQA Assessment Of LNP-Encapsulated IVT mRNA 9/3/2025
   09/03/25 Advancing RNA Newsletter
3. 08.27.25 -- Beyond Solid-Phase Synthesis: The Momentum Of Oligo Manufacturing 8/27/2025
   08/27/25 Advancing RNA Newsletter
4. 08.25.25 -- Services Designed To Take You From Molecule To Market 8/25/2025
   08/25/25 Advancing RNA Newsletter
5. 08.20.25 -- 5 Takeaways From The MHRA mRNA Guidance 8/20/2025
   08/20/25
6. 08.13.25 -- Designing Effective Multivalent mRNA Therapies: Regulatory Considerations 8/13/2025

   08/13/25 Advancing RNA Newsletter

7. 08.07.25 -- Best Practices For CROs In 2025 8/7/2025

   08/07/25 Advancing RNA Newsletter

8. 07.31.25 -- Onshoring Biologics From Discovery To Commercial Drug Product 7/31/2025

   07/31/25 Advancing RNA Newsletter

9. 07.30.25 -- What The EMA mRNA Guidance Means For The Industry 7/30/2025
   07/30/25 Advancing RNA Newsletter
10. 07.24.25 -- Tools For Smarter Antibody Discovery 7/24/2025

    07/24/25 Advancing RNA Newsletter